Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model

Clinical trial NCT01040598 · COMPLETED

Trial details

NCT number: NCT01040598
Sponsor: O & O Alpan LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2009-06-01
Primary completion: 2011-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.